abemaciclib,letrozole,anastrozole
novartis,eli lilly
['breast', 'abema', 'monarch-3', 'abemaciclib']
in monarch-3, abemaciclib added a year to median overall survival of #hr+ #her2- #breastcancer patients. yet we ll have to wait until final analysis to draw conclusion on overall survival benefit. #visualabstract 
A medical communication agency, we help pharmaceutical companies and healthcare professionals explain their scientific content to the target audience.